Dementia
Dementia refers to a significant reduction in cognitive functioning without a change in consciousness, which characterizes a group of diseases that commonly occur during old age, the most common being Alzheimer's. These diseases are characterized by mental and cognitive decline, which leads to significant social and occupational impairments.
Alzheimer's is a disease of the central nervous system characterized by slow and continuous degeneration of nerve cells in the brain until death.
Today these diseases are not included in the list of indications of the Ministry of Health for the treatment of medical cannabis. At the same time, we have dementia patients who respond to treatment and use it. You can apply under various sections or an exception clause. In addition, geriatric patients may apply for a doctor's recommendation without the need for a neurologist's approval.
however
Research
A molecular link between the active component of marijuana and Alzheimer's disease pathology
Eubanks LM, Rogers CJ, Beuscher AE 4th, Koob GF, Olson AJ, Dickerson TJ, Janda KD
Department of Chemistry and Immunology, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California 92037, USA
The role of the endocannabinoid system in Alzheimer's disease: facts and hypotheses
Bisogno T, Di Marzo V
Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, Pozzuoli (Naples), Italy
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation
Ramírez BG, Blázquez C, Gómez del Pulgar T, Guzmán M, de Ceballos ML
Neurodegeneration Group, Cajal Institute, Consejo Superior de Investigaciones Científicas, 28002 Madrid, Spain
A molecular link between the active component of marijuana and Alzheimer's disease pathology
Eubanks LM, Rogers CJ, Beuscher AE 4th, Koob GF, Olson AJ, Dickerson TJ, Janda KD
Department of Chemistry and Immunology, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California 92037, USA
The role of the endocannabinoid system in Alzheimer's disease: facts and hypotheses
Bisogno T, Di Marzo V
Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, Pozzuoli (Naples), Italy
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation
Ramírez BG, Blázquez C, Gómez del Pulgar T, Guzmán M, de Ceballos ML
Neurodegeneration Group, Cajal Institute, Consejo Superior de Investigaciones Científicas, 28002 Madrid, Spain
